Anne Hyland, Bbs, Fca, Cta-aiti
inflammation in humans
BottomLine Termite and Pest
Ms Hyland has a strong track record within the biopharma sector, bringing with her over 25 years of financial experience with both public and private companies. Most recently, she served as Chief Financial Officer of BBI Diagnostics Group Ltd and FTSE-listed Vectura Group plc (LSE: VEC).
Ms Hyland currently serves as Non-executive Director and Chair of the Audit Committee of the FTSE-250 global specialty chemicals company, Elementis plc (LSE:ELM). Prior to Vectura, she held a number of senior finance position, including Director of Corporate Finance at the then FTSE 100 Celltech Group plc, Medeva plc and KPMG.